Concourse Financial Group Securities’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 11126 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 11169 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 11253 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10872 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 11427 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 11458 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 11389 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 11275 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 11016 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 10467 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 10001 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 9410 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 8710 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 8229 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 8500 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 8300 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 8156 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7951 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7814 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7587 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7445 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7244 |
|